መነሻ › ዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ › ማሳቹሴትስ › Boston
በBoston፣ MA ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ 16 ጥናቶች በBoston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Beth Israel Deaconess Medical Center, Boston
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Beth Israel Deaconess Medical Center ( Site 0161), Boston
- Dana Farber Cancer Institute ( Site 0111), Boston
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana-Farber Cancer Institute ( Site 1013), Boston
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Boston Medical Center, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Dana Farber Cancer Institute, Boston
The CARDIOPROTECT Trial
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Beth Israel Deaconess Medical Center, Boston
DALY II USA/ MB-CART2019.1 for DLBCL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana Farber Cancer Institute, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Dana Farber Cancer Institute, Boston
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Massachusetts General Hospital, Boston
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
Emapalumab Prevention of CAR-T Cell Associated Toxicities
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
በሌሎች ከተሞች ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ጥናቶች
- New York City, NY21 ጥናቶች
- Baldwin Park, CA19 ጥናቶች
- Chicago, IL18 ጥናቶች
- Los Angeles, CA17 ጥናቶች
- Houston, TX17 ጥናቶች
- Milwaukee, WI16 ጥናቶች
- Nashville, TN15 ጥናቶች
- Portland, OR15 ጥናቶች
- Philadelphia, PA15 ጥናቶች
- Durham, NC14 ጥናቶች
- Dallas, TX13 ጥናቶች
- Seattle, WA12 ጥናቶች
በBoston ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር111 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር90 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)86 ጥናቶች
- የኮሎሬክታል ካንሰር63 ጥናቶች
- Metastatic Cancer63 ጥናቶች
- የሳንባ ካንሰር62 ጥናቶች
- የእንቁላል ካንሰር61 ጥናቶች
- የፕሮስቴት ካንሰር59 ጥናቶች
- ዲፕሬሽን52 ጥናቶች
- የኤንዶሜትሪየም ካንሰር50 ጥናቶች
- የልብ ድካም44 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ44 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።